Eli Lilly and Co (LLY)
756.05
-20.70
(-2.66%)
USD |
NYSE |
May 02, 16:00
746.05
-10.00
(-1.32%)
After-Hours: 20:00
Eli Lilly Price to Book Value: 56.08 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 57.62 |
| April 30, 2024 | 57.94 |
| April 29, 2024 | 54.69 |
| April 26, 2024 | 54.41 |
| April 25, 2024 | 53.77 |
| April 24, 2024 | 54.31 |
| April 23, 2024 | 55.31 |
| April 22, 2024 | 54.25 |
| April 19, 2024 | 53.88 |
| April 18, 2024 | 55.33 |
| April 17, 2024 | 55.69 |
| April 16, 2024 | 55.39 |
| April 15, 2024 | 55.69 |
| April 12, 2024 | 55.76 |
| April 11, 2024 | 56.35 |
| April 10, 2024 | 56.52 |
| April 09, 2024 | 56.17 |
| April 08, 2024 | 57.66 |
| April 05, 2024 | 58.17 |
| April 04, 2024 | 56.98 |
| April 03, 2024 | 57.56 |
| April 02, 2024 | 56.67 |
| April 01, 2024 | 56.42 |
| March 31, 2024 | |
| March 28, 2024 | 68.67 |
| Date | Value |
|---|---|
| March 27, 2024 | 68.68 |
| March 26, 2024 | 68.40 |
| March 25, 2024 | 68.24 |
| March 22, 2024 | 68.02 |
| March 21, 2024 | 67.99 |
| March 20, 2024 | 68.22 |
| March 19, 2024 | 68.21 |
| March 18, 2024 | 67.32 |
| March 15, 2024 | 66.57 |
| March 14, 2024 | 67.14 |
| March 13, 2024 | 66.89 |
| March 12, 2024 | 66.63 |
| March 11, 2024 | 64.82 |
| March 08, 2024 | 67.27 |
| March 07, 2024 | 68.86 |
| March 06, 2024 | 68.83 |
| March 05, 2024 | 68.63 |
| March 04, 2024 | 69.93 |
| March 01, 2024 | 69.03 |
| February 29, 2024 | 66.52 |
| February 28, 2024 | 66.87 |
| February 27, 2024 | 67.48 |
| February 26, 2024 | 68.09 |
| February 23, 2024 | 67.88 |
| February 22, 2024 | 67.89 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
24.93
Minimum
Feb 14 2022
69.93
Maximum
Mar 04 2024
38.05
Average
35.00
Median
Jul 07 2021
Price to Book Value Benchmarks
| Amgen Inc | 23.95 |
| Madrigal Pharmaceuticals Inc | 10.60 |
| Vertex Pharmaceuticals Inc | 5.878 |
| Viking Therapeutics Inc | 8.944 |
| Moderna Inc | 3.473 |
Price to Book Value Related Metrics
| PE Ratio | 113.24 |
| PS Ratio | 18.99 |
| PEG Ratio | 14.39 |
| Price | 756.05 |
| Earnings Yield | 0.88% |
| Market Cap | 718.55B |
| PEGY Ratio | 13.36 |
| Operating PE Ratio | 56.68 |
| Normalized PE Ratio | 74.58 |